Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
about
Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.Active efflux mechanisms for antimicrobial resistance.Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.Sequential acquisition of norfloxacin and ofloxacin resistance by methicillin-resistant and -susceptible Staphylococcus aureusIn vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance risesRelationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones.Mode of action of sulfanilyl fluoroquinolonesIntracellular accumulation of norfloxacin in Mycobacterium smegmatisLack of effect of carbonyl cyanide m-chlorophenylhydrazone on KB-5246 accumulation by Staphylococcus aureus.Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus.Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.Mechanisms of quinolone resistance.Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.Different kinetic of enzymatic inactivation of lincomycin and clindamycin in Staphylococcus aureus.
P2860
Q33976061-2E5A9EDA-E220-4088-A5BE-1B04FB5ED59FQ35138154-7C129B72-CF29-4C4C-9128-85109B1C1D70Q35701032-0A86F981-61B7-4DE2-A233-E2414DEE60D8Q35893473-8F3915AA-98EC-4654-9C86-A5C678CAFF91Q35899647-3F6641F7-B10F-4AD0-9D2F-DC35767C845BQ36757105-0ED7D4BC-6226-4B07-8361-A95DD5F1D5EBQ36758128-E8C4D414-7C99-4D96-A0A8-08DAEC65176AQ39557785-39450347-4927-4FCB-9884-AC264900EF50Q39780762-9E4C4D23-98C6-4579-B4B6-3982F7CD8FB6Q39871854-7FCA21C2-E315-4A3D-83D1-0B0EA2EAA800Q40087982-C6593B80-9E6F-47DF-8A28-A8DCE3940710Q40088128-DC84CC2F-42D8-4177-8258-490307827F4AQ40088314-BCAFD7B0-EFB2-4B17-9EE1-63A3DE9E6E17Q40088541-8A22A313-5D7E-4F70-8626-2D63600AB0B9Q40633568-BCCAAD97-D137-4BA6-AE8C-24CF714F39BBQ42948655-ED9F818B-141B-4DE3-B498-6A0F4CDDC355Q54234856-97008357-2EB4-4F8F-AC68-94F9DCD9EA31
P2860
Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
@en
type
label
Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
@en
prefLabel
Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
@en
P2093
P2860
P356
P1476
Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
@en
P2093
P2860
P304
P356
10.1128/AAC.35.2.368
P407
P577
1991-02-01T00:00:00Z